
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
The current HEMO market cap is 12.2M. The company's latest EPS is GBP -1.8563 and P/E is -1.79.
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
GBP (£) | GBP (£) | GBP (£) | GBP (£) | GBP (£) | |
Total Revenue | 0 | 0 | 0 | 0 | 0 |
Operating Income | -1.46M | -2.13M | -2.66M | -5.53M | -5.21M |
Net Income | -1.45M | -2.08M | -5.1M | -3.98M | -6.69M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
GBP (£) | GBP (£) | GBP (£) | GBP (£) | GBP (£) | |
Total Assets | 1.05M | 2.67M | 8.52M | 7.09M | 6.11M |
Total Liabilities | 1.4M | 1.79M | 353k | 3.85M | 3.33M |
Total Equity | -349k | 876k | 8.17M | 3.24M | 2.78M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
GBP (£) | GBP (£) | GBP (£) | GBP (£) | GBP (£) | |
Operating | -1.2M | -1.8M | -2.63M | -2.9M | -6.11M |
Investing | 2k | -170k | -939k | -420k | -32k |
Financing | -39k | 3.21M | 8.78M | -110k | 4.45M |
Market Cap | 12.2M |
Price to Earnings Ratio | -1.79 |
Price to Sales Ratio | 0 |
Price to Cash Ratio | 9.62 |
Price to Book Ratio | 4.32 |
Dividend Yield | - |
Shares Outstanding | 3.6M |
Average Volume (1 week) | 11.77k |
Average Volume (1 Month) | 11.35k |
52 Week Change | -73.55% |
52 Week High | 1,600.00 |
52 Week Low | 275.00 |
Spread (Intraday) | 21 (6.02%) |
Company Name | Hemogenyx Pharmaceuticals Plc |
Address |
6 heddon street london W1B 4BT |
Website | https://hemogenyx.com |
Industry | finance services (6199) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions